How to Buy Edwards Lifesciences Stock
Edwards Lifesciences Corp
Edwards Lifesciences is a medical device company located in California, United States, which is part of the Healthcare sector, and is traded under the ticker EW on the NYSE exchange.
Edwards Lifesciences stock last closed at $83.98, up 0.57% from the previous day, and has increased 11.71% in one year. It has overperformed other stocks in the Medical Devices industry by 0.72 percentage points. Edwards Lifesciences stock is currently +16.15% from its 52-week low of $72.30, and -4.45% from its 52-week high of $87.89.
At the moment, there are 580M shares of EW outstanding. The market value of EW is $48.71B. In the last 24 hours, 6.11M EW shares were traded.
How to Buy Edwards Lifesciences Stock
Wondering how to invest in Edwards Lifesciences stock? Here's how.
- Choose where to buy Edwards Lifesciences stock: You need to decide on a stock brokerage, but don't worry - we've tested dozens of online stock brokerages and apps to help you choose where to buy Edwards Lifesciences stock.
- Create your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
- Fund your investment account: Choose your method of payment and add your details.
- Analyze Edwards Lifesciences stock: The Edwards Lifesciences ticker symbol is EW. Is Edwards Lifesciences stock a good investment? Should you buy shares of EW? How do EW's underlying business fundamentals look? Do top analysts think Edwards Lifesciences is a good buy? Why has EW's stock price moved recently? (Hint: Our stock research tools can help you evaluate if EW is a good stock to buy).
- Place your EW trade: Decide if you will purchase EW shares at the current market price or use a limit order to purchase EW shares at a particular price.
- Keep an eye on your EW investment: Create a watchlist to watch your new investment in Edwards Lifesciences shares.
Step 1: Choose where to buy Edwards Lifesciences stock
You will need an online brokerage account in order to access the NYSE market and buy EW shares.
Our favorite brokerage: eToro
Based on our analysis, eToro is the best brokerage. Here's why:
- You can invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
- Access to world markets: From Technology to Utilities, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading stock exchanges.
- Social investing: eToro offers a community of more than 20 million users globally. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your stock purchase by creating an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Create your brokerage account
Now that you've picked the right brokerage, you'll need to fill out some personal details so you are able to buy EW stock today.
How to Set Up a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal data to create your new brokerage account.
- Send your details by pressing the "Create Account" button. Get started with eToro today
Step 3: Fund your investment account
Now that you've created your account on one of the most highly reviewed stock market apps, you need to deposit funds:
Check out the walkthrough below if you need help transferring funds into your new brokerage account.
Step 4: Analyze Edwards Lifesciences stock
Once you have chosen the best place to buy Edwards Lifesciences stock, it's absolutely critical to analyze their stock prior to buying, so you actually comprehend the risk and opportunity.
Edwards Lifesciences stock data
Edwards Lifesciences Due Diligence Checks
WallStreetZen was built to help average investors do more in-depth fundamental analysis quickly.
You can view all of the due diligence checks on EW's stock page.
How is EW stock valued?
You can use a variety of different financial metrics, analyses, models, and charts to gauge EW's fair value.
Using relative valuations ratios:
- EW could be overvalued based on its P/E ratio of 45.64x, relative to Medical Devices industry P/E ratio of 20.43x
- EW may be overvalued based on its P/B ratio of 4.71x, relative to Medical Devices industry P/B ratio of 3.03x
- EW may be overvalued based on its PEG ratio of 1.68x
You can do additional valuation research on EW's stock here.
A look at EW Cashflows and Balance Sheet
Passed Financial Due Diligence Checks:
- There are more short-term assets than long-term liabilities on the EW balance sheet.
- EW earnings of $1.31B is not sufficient to cover its interest payments.
- EW's operating cash flow of $1.60B allows it to safely service it's debt of $705.40M.
- There are more short-term assets than short-term liabilities on the EW balance sheet.
- Total EW debt is lower than 5 years ago, relative to shareholder equity.
- EW has a low debt to equity ratio of 0.33.
Failed Financial Due Diligence Checks:
- EW profit margin has gone down from 76.7% to 17.7% in the past year.
Is it a good time to buy EW stock, according to analysts?
Out of 16 Equities analysts who research EW, the consensus analyst rating on EW is a Strong Buy
Please note that analyst ratings are not recommendations, nor are they investment advice.
Latest EW Analyst Upgrades/Downgrades
David Rescott, a top 21% analyst from Baird maintains EW with a hold rating and raises their EW price target from $85.00 to $87.00, on Apr 24, 2026.
Anthony Petrone, a top 12% analyst from Mizuho maintains EW with a buy rating and lowers their EW price target from $100.00 to $95.00, on Apr 13, 2026.
David Roman, a bottom 8% analyst from Goldman Sachs maintains EW with a strong buy rating and lowers their EW price target from $108.00 to $95.00, on Feb 11, 2026.
Adam Maeder, a top 27% analyst from Piper Sandler reiterates EW with a strong buy rating and raises their EW price target from $98.00 to $100.00, on Feb 11, 2026.
Piper Sandler's Adam Maeder raised their price target on Edwards Lifesciences (NYSE: EW) by 2% from $98 to $100 on 2026/02/11. The analyst reiterated their Strong Buy rating on the stock.
Edwards Lifesciences reported its Q4 and FY 2025 earnings.
According to Maeder, TAVR business strength was the driving force behind the quarter's "robust" performance.
Following "generally great" commentary from Edwards Lifescience management, the analyst said they are more optimistic on the company's setup moving ahead
Maeder predicted a post-print bump for the stock price.
Earnings Report
Edwards Lifesciences reported:
For Q4 2025:
- EPS of $0.58, which missed the Zacks Consensus Estimate by 5.89% and, by 1.7%, Q4 2024’s $0.59.
- Revenue of $1.57B, which beat the Zacks Consensus Estimate by 1.99% and, by 13.3%, Q4 2024’s $1.39B.
For FY 2025:
- EPS of $2.56, up 5.3% Y/Y.
- Revenue of $6.07B, up 11.5% Y/Y.
Management guided:
For Q1 2026:
- EPS of $0.70 to $0.76.
- Revenue of $1.55B and $1.63B.
For FY 2026:
- EPS of $2.90 to $3.05.
- Revenue growth of 8% to 10%
CEO Bernard Zovighian commented: “Edwards’ strong Q4 and FY performance in 2025 reflects our differentiated strategy with a clear vision around three key elements: focusing solely on structural heart, solving large, urgent, and very complex patient needs, and pursuing unique opportunities to innovate and lead, all achieved through excellent execution by our deeply experienced teams.
“Based on multiple catalysts and the company’s strong fourth quarter performance, we have increased confidence in our outlook for 2026 and believe that our 70 years of expertise in valve innovation and world-class evidence will create sustainable growth and expanded profitability.
“These enduring catalysts benefiting Edwards in 2026 and the years ahead include distinguished long-term results unique to Edwards from the PARTNER 3 7-year and PARTNER 2 10-year trials, the impact of the practice-changing EARLY TAVR trial, new guidelines for treating aortic stenosis patients in Europe and the approvals of the first transcatheter mitral replacement therapy.
“We expect additional meaningful catalysts later in 2026 to fuel sustainable growth into the future, including next-generation TEER, PASCAL for U.S. tricuspid patients, continued scaling of EVOQUE and the potential of increased patient access from an updated TAVR NCD.”
Larry Biegelsen, a top 21% analyst from Wells Fargo maintains EW with a strong buy rating and raises their EW price target from $96.00 to $100.00, on Feb 11, 2026.
You can dig deeper into what analysts are forecasting on the Edwards Lifesciences stock forecast page.
EW Momentum
Is EW Growing Revenue?
Last year, EW earnings were $1.07B. During the last 5 year, EW's earnings have grown by 6.87% per year. This was slower than the Medical Devices industry average of 20.67%.
Last year, EW revenue was $6.07B. Over the past five year, EW's revenue has gone up by 6.7% per year. This was slower than the Medical Devices industry average of 10.81%.
Dig into EW's earnings and revenue performance here.
Who is buying/selling EW?
In the past year, executives and large shareholders at EW have sold more shares than they have bought.
Scott B. Ullem, CVP Chief Financial Officer of EW, was the latest EW insider to buy. They bought $770,341.00 worth of EW shares on Apr 9, 2026.
Learn more about who owns EW stock here.
Can I rely on EW as an income stream?
No, Edwards Lifesciences doesn't provide an income stream by paying out dividends.
What do other investors have to say about EW?
One of the biggest reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other investors have to say.
Step 5: Place your EW trade
There are two main types of orders:
- Market order: A market order is an order to buy or sell a security at the best possible price.
Market orders are mostly fine for most investors. - Limit order: A limit order allows you to buy or sell a security at a specific price (or better).
If you want to be sure you're buying or selling at a particular dollar amount, place a limit order.
Press the Open button and your broker will execute your order.
If you require additional help investing in stocks on eToro, click the helpful video below:
Step 6: Keep an eye on your EW investment
Now that you own some EW stock, you'll want to stay up-to-date on your stock purchase.
Put EW on a watchlist to get the latest updates about your EW stock.
EW Feed
How to Buy Stock in Edwards Lifesciences
To summarize, here are the 6 steps for buying Edwards Lifesciences stock:
- Choose where to buy Edwards Lifesciences stock
- Create your brokerage account
- Fund your investment account
- Analyze Edwards Lifesciences stock
- Place your EW trade
- Keep an eye on your EW investment
If you require a online brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you would like to keep an eye on your investment in Edwards Lifesciences, get started below.
More Articles You Might Like
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.